These findings are consistent with those of previous studies that reported that adavosertib significantly upregulates apoptosis markers, including γ-H2AX and cleaved PARP, in p53 MT cells [14,49], supporting its apoptotic effect in p53-mutant GIST models. This evidence concerns the gene TP53 and gastrointestinal stromal tumor.